Approval · Notice of Compliance 2936 · 1998
OMNISCAN: Notice of Compliance 2936
Issued June 17, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2936
- Date
- June 17, 1998
- Company
- Nycomed Imaging A.S.Oslo, Saone Et Loire, Norway
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for approval for the use of omniscan for body imaging
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNISCAN | Not yet assigned | — |
Medicinal ingredients
- GADODIAMIDE 287 MG per ML